BFAM
Bright Horizons Family Solutions Inc.
BFAM's outlook is improving, though it still trails on the overall score.
NKE
NIKE, Inc.
NKE has the edge over BFAM overall, supported by stronger valuation and stronger fundamentals.
BFAM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
BFAM's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
BFAM PE Valuation
BFAM has no meaningful PE right now: it lost money over the past year.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
BFAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
BFAM has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
BFAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.47 | — |
| Q3 2026 | -$2.97 | -185% |
| Q2 2026 | $3.16 | +3.6% |
| Q1 2026 | $3.32 | +20% |
| Q4 2025 | $3.36 | +40% |
| Q3 2025 | $3.48 | +74% |
| Q2 2025 | $3.05 | +74% |
| Q1 2025 | $2.77 | +94% |
| Q4 2024 | $2.40 | +88% |
BFAM has swung to a loss: it lost $2.97 per share over the past year, after a profit the year before.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over BFAM on earnings quality, reporting a profit while its opponent remains loss making.
BFAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $841.5M | +4.8% |
| Q2 2026 | $779.2M | +6.5% |
| Q1 2026 | $712.2M | +7% |
| Q4 2025 | $733.7M | +8.8% |
| Q3 2025 | $802.8M | +12% |
| Q2 2025 | $731.6M | +9.2% |
| Q1 2025 | $665.5M | +6.9% |
| Q4 2024 | $674.1M | +9.5% |
BFAM has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -22% | -37 points |
| Q2 2026 | 10% | -1.5 points |
| Q1 2026 | 9.1% | -0.2 points |
| Q4 2025 | 6.2% | -1 points |
| Q3 2025 | 15% | +2.6 points |
| Q2 2025 | 12% | +1.4 points |
| Q1 2025 | 9.4% | +2.9 points |
| Q4 2024 | 7.2% | +2.6 points |
BFAM's operating margin was −22% last quarter, down 37 points from the same quarter a year ago, near the bottom of its range since 2019.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over BFAM on profitability, with a higher operating margin.
BFAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$25.1M | +$17.4M |
| Q2 2026 | $76.1M | -34% |
| Q1 2026 | $87.6M | +23% |
| Q4 2025 | $114.7M | +29% |
| Q3 2025 | -$42.4M | -$10.3M |
| Q2 2025 | $115.4M | +33% |
| Q1 2025 | $70.9M | -27% |
| Q4 2024 | $88.6M | +37% |
BFAM has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
BFAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -6.4% | -3.3M shares |
| 1 year | -16% | -9M shares |
| 3 years | -17% | -9.6M shares |
| 5 years | -20% | -11.9M shares |
| Available history | -18% | -10.5M shares |
BFAM has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $88M |
| Q2 2026 | $246.7M |
| Q1 2026 | $224.8M |
| Q4 2025 | $120.7M |
| Q3 2025 | $44.3M |
| Q2 2025 | $40.8M |
| Q1 2025 | $19.6M |
| Q4 2023 | — |
BFAM spent $680M buying back its own shares over the past year.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
BFAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 9.5x | High |
| Q2 2026 | 2.3x | Moderate |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.4x | Moderate |
BFAM's net debt is about 9.5 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over BFAM on leverage, with a lower net debt burden relative to earnings.
BFAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 7.9 | Oversold |
BFAM's weekly RSI is 30 (neutral) and its Stochastic is 8 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
BFAM PE vs Consumer Cyclical Sector
| Metric | BFAM | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 25% above |
| PE % | 6 | 47 | 41 pts below |
BFAM has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over BFAM on valuation relative to its sector.
BFAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.9 | 16% below |
| 20 week MA | $68.6 | 23% below |
| 50 week MA | $76.3 | 31% below |
| 100 week MA | $96.6 | 45% below |
| 200 week MA | $98.9 | 47% below |
BFAM is in a downtrend: it's below all five of its weekly moving averages, and 47% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over BFAM on trend strength, trading above more of its moving averages.
BFAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $150.9 | $165.3 | +9.6% |
| 2021 | $165.3 | $123.2 | -25% |
| 2022 | $123.2 | $59.9 | -51% |
| 2023 | $59.9 | $94.2 | +57% |
| 2024 | $94.2 | $110.5 | +17% |
| 2025 | $110.5 | $101.3 | -8.3% |
| 2026 YTD | $101.3 | $52.8 | -48% |
BFAM has finished lower in three of the last six years. It's down 48% so far in 2026.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over BFAM on returns for 2026, with the stronger performance.